Contract Services
Paras Biopharmaceuticals to expand global outreach of its ‘Biosimilar Development & Partnership’
Bioseet, based in Munich, Germany, is an enterprise encompassing a virtual marketplace and teamspace for Biosimilar and other generic assets to facilitate ...
March 03, 2022 | News
PharmAbcine Announces Last Patient Last Visit in its Phase Ib mTNBC Combination Trial
The clinical study, which had the first patient dosed in December 2018, evaluated the safety and clinical efficacy of olinvacimab, the Company's anti-...
February 28, 2022 | News
Moderna and Thermo Fisher Scientific Announce Long-Term Strategic Collaboration
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Thermo Fisher Scientific Inc. (NYS...
February 25, 2022 | News
Catalent Expands Temperature-Controlled Clinical Supply Capabilities in Shanghai, China
The facility will be expanded by approximately 30,000 square feet (approximately 2,800 square meters), which will double the clinical storage capacity...
February 16, 2022 | News
WuXi STA Wins 2022 CMO Leadership Awards in All Six Core Categories
For the 2022 CMO Leadership Awards, Life Science Leader Magazine teamed up with Industry Standard Research (ISR) to conduct the Contract Manufacturing Qual...
February 11, 2022 | News
X-Chem and Excelra’s GOSTAR Join Forces to Advance Drug Discovery for Challenging Targets
Machine learning and artificial intelligence are reshaping discovery and optimization of drug candidates. This synergistic new partnership between Excelra&...
February 10, 2022 | News
National Cancer Center Japan and GenScript ProBio Enter Research Collaboration Agreement for a Plasmid & Lentiviral vector CMC development
The project initialized by National Cancer Center Research Institute. Under the agreement, National Cancer Center and GenScript Biotech will collaborate on...
February 07, 2022 | News
Biogen to acquire full ownership of Samsung Bioepis
Agreement with Biogen to buyout Biogen's (50% -1 share) stake in Samsung Bioepis Joint Venture for up to USD $2.3 billion Transaction projected to ...
January 28, 2022 | News
GenScript ProBio initiates a CDMO Contract For Next-Generation CD47 Antibody with InnoBation Bio
InnoBation Bio, led by Seung-gu Kim (CEO), is a biopharmaceutical company specializing in the development of biomarkers, Chimeric Antigen Receptor (CAR) T ...
January 26, 2022 | News
WuXi STA Launches its First Parenteral Formulation Manufacturing Line
The industry-leading automatic parenteral filling line features multiple filling modules and a built-in lyophilizer to fill vials, syringes, and ...
January 24, 2022 | News
GenScript ProBio to Expand Commercial cGMP Plasmid and Viral Vector
On January 19, 2022, GenScript ProBio broke ground for the construction of its newest plasmid and viral vector manufacturing facility, a 34,000-square...
January 21, 2022 | News
Vetter's new clinical manufacturing site now officially authorized
Important milestone reached for the new site Additional filling capacities for early-stage clinical development First customer audits already completed...
January 20, 2022 | News
Avance Clinical Announces Major PE Investment for US Expansion at Biotech Showcase 2022
Avance Clinical is taking meetings with biotechs to discuss the benefits of conducting trials in Australia, including no IND requirement and an attractive ...
January 18, 2022 | News
WuXi Biologics completes the first GMP inspection in 2022
WuXi Biologics a global company with leading open-access biologics technology platforms, announced that it has completed a remote GMP inspection by&n...
January 18, 2022 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
